yüz atletik Biz cowboy rägn kappa Çok Anıtsal hamile
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
新型コロナウイルス感染症に関する 国内外の研究開発動向について
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
Guideline Therapeutics and COVID-19: living guideline
PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library
Frontiers | The Mechanism of Lung and Intestinal Injury in Acute Pancreatitis: A Review
ACWI ex JAPAN ex CHINA A 2022 May SAIR Constituent
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
Carnosine improves aging‐induced cognitive impairment and brain regional neurodegeneration in relation to the neuropathological alterations in the secondary structure of amyloid beta (Aβ) - Banerjee - 2021 - Journal of Neurochemistry - Wiley Online Library
Biophysical fitness landscape of the SARS-CoV-2 Delta variant receptor binding domain | bioRxiv
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2 - eBioMedicine
Rapid characterization of spike variants via mammalian cell surface display - ScienceDirect
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates | Science Translational Medicine
Cancers | Free Full-Text | STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy | HTML
Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
Rapid characterization of spike variants via mammalian cell surface display | bioRxiv
Rapid characterization of spike variants via mammalian cell surface display
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports